Advertisement

Percutaneous closure of a large atrial septal defect presenting with acute severe hemolysis

  • Manli Yu
  • Xinghua Shan
  • Yuan Bai
  • Yongwen Qin
  • Xianxian ZhaoEmail author
Letter to the Editors
  • 8 Downloads

Sirs:

Hemolysis induced by occlude devices to repair the structural cardiac defects is not very infrequent in intervention cardiology. The unavoidable residual leaks, which are featured by high velocity, vortices, and rapid deceleration, impose significant shear on red blood cells leading to hemolysis [1, 2]. There are several cases that reported acute hemolysis after transcatheter closure of VSD or PDA in the literature [3, 4]. However, hemolysis due to intracardiac device for ASD closure is rather rare. Although in some cases surgical removal of the device or transcatheter occlusion of a residual shunt may be necessary, most hemolysis can be conservatively managed with fluids, sodium bicarbonate, and corticosteroids.

A 51-year-old female weighing 54 kg was admitted to the catheter lab with the aim of performing a transcatheter device closure of ASD. She presented a 2-year history of exertional chest distress. The second heart sound was prominent, and a grade 3/6 systolic murmur was...

Notes

Funding

This study was supported by the National Natural Science Foundation of China (81400287). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

References

  1. 1.
    Alushi B, Lauten A, Cassese S, Colleran R, Schüpke S, Rai H, Schunkert H, Meier B, Landmesser U, Kastrati A (2018) Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials. Clin Res Cardiol 107:788–798CrossRefGoogle Scholar
  2. 2.
    Frank D, Abdel-Wahab M, Gilard M, Digne F, Souteyrand G, Caussin C, Collart F, Letocart V, Wöhrle J, Kuhn C, Hovorka T, Baumgartner H (2018) Characteristics and outcomes of patients ≤ 75 years who underwent transcatheter aortic valve implantation: insights from the SOURCE 3 Registry. Clin Res Cardiol.  https://doi.org/10.1007/s00392-018-1404-2. (Epub ahead of print)Google Scholar
  3. 3.
    Spence MS, Thomson JD, Weber N, Qureshi SA (2006) Transient renal failure due to hemolysis following transcatheter closure of a muscular VSD using an Amplatzer muscular VSD occluder. Catheter Cardiovasc Interv 67:663–667CrossRefGoogle Scholar
  4. 4.
    Godart F, Rodes J, Rey C (2000) Severe haemolysis after transcatheter closure of a patent arterial duct with the new Amplatzer duct occluder. Cardiol Young 10:265–267Google Scholar
  5. 5.
    Butera G, De Rosa G, Chessa M et al (2003) Transcatheter closure of atrial septal defect in young children: results and follow-up. J Am Coll Cardiol 42:241–245CrossRefGoogle Scholar
  6. 6.
    Butera G, Romagnoli E, Carminati M et al (2008) Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients. Am Heart J 156:706–712CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.1Department of Cardiovasology, Changhai HospitalSecond Military Medical UniversityShanghaiChina

Personalised recommendations